Zenith Health Care shareholders approved the company’s audited financial statements for the year ended March 31, 2026, and key management appointments during its 32nd Annual General Meeting. The meeting, held via video conferencing on August 28, 2026, also saw the authorization of a material related-party transaction.

The proceedings commenced at 10:30 am and concluded at 10:44 am. Members present included 39 shareholders, comprising 10 from the promoter group and 29 public shareholders. The statutory auditors’ report and secretarial audit report were submitted without any qualifications.

Governance and Management Changes

The board secured shareholder approval for several governance-related resolutions:

• Re-appointment of Mrs. Neela M. Raycha as a director, replacing her term that expired by rotation.
• Re-appointment of Mr. Mahendra C. Raycha as Managing Director.
• Regularization of Mr. Akshit M. Raycha’s appointment as Joint Managing Director/Whole Time Director.

These appointments ensure continuity in the company’s leadership structure for the upcoming fiscal year.

Related Party Transaction

Shareholders approved a material related-party transaction with Achyut Healthcare Limited. The resolution authorizes the Board of Directors to enter into this transaction, subject to regulatory compliance.

Voting Process

The company facilitated e-voting through the National Securities Depository Ltd. (NSDL) system before, during, and for 15 minutes after the meeting. M/s Kamlesh M. Shah was appointed as the scrutinizer to supervise the voting process. The consolidated scrutinizer’s report and final voting results will be submitted to stock exchanges by September 1, 2026, and uploaded to the company’s website.

Zenith Health Care returned to profitability in the first quarter of FY27, reporting a net profit after tax of ₹13.62 lakh for the period ended June 30, 2026. This stands in contrast to the net loss of ₹34.20 lakh recorded in the immediately preceding quarter (Q4FY26) and a marginal loss of ₹1.88 lakh in the corresponding quarter of FY26.

Revenue from operations expanded by 5.6% year-on-year to ₹350.12 lakh, up from ₹331.69 lakh in Q1FY26. The company also saw sequential growth in revenue, rising from ₹271.83 lakh in Q4FY26.

Financial Performance

The Board of Directors approved the unaudited standalone financial results in a meeting held on August 14, 2026. Key financial metrics for the quarter are detailed below:

For the full year ended March 31, 2026, the company reported total income from operations of ₹1,093.65 lakh and a net profit after tax of ₹0.51 lakh.

What the Numbers Show

The return to profitability was supported by improved pre-tax earnings, which stood at ₹18.12 lakh in Q1FY27 compared to a pre-tax loss of ₹42.33 lakh in the previous quarter. The effective tax rate for the quarter was approximately 24.8%, calculated on the net profit before tax figure. There were no exceptional or extraordinary items impacting the results for the current quarter, indicating that the profit turnaround was driven by core operational performance rather than one-off gains.

The company’s paid-up equity share capital remains unchanged at ₹537.39 lakh. Reserves as shown in the audited balance sheet of the previous year stood at ₹205.03 lakh.